Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-059896
Filing Date
2012-11-21
Accepted
2012-11-21 11:20:06
Documents
1
Period of Report
2012-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd361071.html 4  
1 FORM 4 rrd361071.xml 4 7118
  Complete submission text file 0001181431-12-059896.txt   8804
Mailing Address 107 NORTH RYDE SYDNEY C3 1670
Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088
NOVOGEN LTD (Reporting) CIK: 0001075880 (see all company filings)

Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 121220083
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations